Tirzepatide associated with greater weight loss in women than men All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this years Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept)
Verified Patient GLP-1 receptor agonists have been prescribed (on-and-off label) for weight management, including obesity, along with a reduced caloric diet and increased physical activity
Osteoporos Int 26:209218 Gao L, Li SL, Li YK (2018) Liraglutide promotes the osteogenic differentiation in MC3T3-E1 cells via regulating the expression of Smad2/3 through PI3K/Akt and Wnt/beta-catenin pathways
In contrast to the effects of sweet taste on GLP-1 release, glucagon secretion decreases in response to sweet taste perception, indicating that glucagon is expressed in a different population of type II taste buds than those that express GLP-1 and GLP2 (67)
One more thingIGF-1 LR3 might also help downregulate glucocorticoids
Oxidative stress represents another shared mechanism